Investors

Listed on the Canadian Securities Exchange (CSE): COOL & OTC Markets (OTCQX): CLABF. Frankfurt: LD62, WKN: A2P8K3

Highlights

Delivery system
  • Patented nanostrip technology
  • Can further expand into other drugs
  • $15MM + facility currently in production
R&D
  • Patent pending technology
  • One of few Health Canada Licesensed Dealer Labs
  • API Grade
Clinics
  • 200,000 + patients
  • Clinical Trials
  • Expansion to new locations
Opportunity
  • Fully funded
  • $20MM + invested capital
  • New world-class management team

Trading Chart


Profile

CUSIP 21872J
ISIN CA21872J2083
Incorporated BC / Dec 3 2019
Fiscal Year End Dec 31
Industry Junior industrial

Consultants

Legal Counsel
Cassels
Auditor
Dale Matheson, Carr-Hilton Labonte LLP
Transfer Agent
Computershare Trust Company of Canada